Thus, there is no reason to recommend any form of genetic testing in MHT users except for thrombophilia testing (prothrombin G20210A mutation or factor V Leiden mutation) in women with a personal and/or family history of thrombosis [3]. The gene discussed is F5; the disease is Rare hereditary thrombophilia.